XBKK
TNL
Market cap219mUSD
Nov 05, Last price
24.00THB
Name
Thanulux PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Thanulux Public Company Limited, a Bangkok, Thailand-based enterprise founded in 1975, specializes in the production, subcontracting, and distribution of a diverse range of apparel and leather products. Serving men, women, and children, the company's extensive offerings for the Thai market encompass everyday garments such as shirts, T-shirts, trousers, suits, and jackets, alongside intimate apparel, sleepwear, towels, scarves, swimwear, sportswear, maternity clothes, and various accessories like socks, jeans, and neckties. Its leather goods division crafts wallets, handbags, and belts. Beyond standard clothing, Thanulux also provides garments for infants and a comprehensive selection of toddler necessities, including diapers, bedding, footwear, socks, dolls, and other accessories. The company's capabilities extend to healthcare and medical textile products, manufacturing items like medical uniforms, surgical kits, and patient gowns, in addition to medical devices such as syringes and disinfectant wipes. Furthermore, it produces professional uniforms and workwear, as well as ceremonial Buddhist monk robes and white dharma practice robes under its Thammarat and Thammasorn brands. Thanulux supplies its vast product line to a wide array of clients, including private businesses, financial institutions, petrochemical corporations, educational establishments, automotive companies, healthcare providers, hospitals, hotels, and spas. The company maintains an international presence, exporting its goods to markets across Europe, Asia, the United States, Australia, and South Africa.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||